Sep 9 2015
Technavio has published a new report on the global cardiovascular implants market, which is expected to grow at a CAGR of over 4% from 2015-2019.
About the Report
According to the new report by Technavio, the prevalence of cardiovascular conditions such as myocardial infarction, bradycardia, sick sinus syndrome, atrioventricular blocks, ventricular fibrillation, cardiac arrest, tachycardia, and coronary artery disease, has increased in recent times. About 17.5 million died from cardiovascular disorders in 2012, accounting for 31% of the overall deaths worldwide.
“To decrease the mortality rate of cardiac diseases, cardiovascular implants such as ICDs and artificial heart valves are used as rapid lifesaving measures,” says Faisal Ghaus, Vice President of Technavio.
The latest report by Technavio also emphasizes the advances in technology, which have led to the development of more accurate cardiovascular implant surgeries like robot-assisted surgeries that provide better support to patients and surgeons.
“The awareness of the benefits of robot-assisted surgeries will drive many hospitals to install and implement such equipment, which will stimulate market growth during the forecast period,” adds Ghaus.
Market Scope and Calculation of Market Size
The new Technavio report covers the present scenario and growth prospects of the global cardiovascular implants market from 2015-2019. To calculate the market size, we use revenue generated from the sales of cardiovascular implants such as CRTs, ICDs, implanted cardiac pacemakers, coronary stents, peripheral stents, and heart valves.
Source: http://www.technavio.com/